AbbVie is is currently undergoing testing and trials of KALETRA® /Aluvia (lopinavir/ritonavir)* against COVID-19.
Rankings by 
Национальный рейтинг
66th
in United StatesРегиональный рейтинг
72nd
in North America and CaribbeanГлобальный рейтинг
177th
worldwide